Wall shear stress is decreased in the pulmonary arteries of patients with pulmonary arterial hypertension: An image-based, computational fluid dynamics study

Previous clinical studies in pulmonary arterial hypertension (PAH) have concentrated predominantly on distal pulmonary vascular resistance, its contribution to the disease process, and response to therapy. However, it is well known that biomechanical factors such as shear stress have an impact on endothelial health and dysfunction in other parts of the vasculature. This study tested the hypothesis that wall shear stress is reduced in the proximal pulmonary arteries of PAH patients with the belief that reduced shear stress may contribute to pulmonary endothelial cell dysfunction and as a result, PAH progression. A combined MRI and computational fluid dynamics (CFD) approach was used to construct subject-specific pulmonary artery models and quantify flow features and wall shear stress (WSS) in five PAH patients with moderate-to-severe disease and five age- and sex-matched controls. Three-dimensional model reconstruction showed PAH patients have significantly larger main, right, and left pulmonary artery diameters (3.5 ± 0.4 vs. 2.7 ± 0.1 cm, P = 0.01; 2.5 ± 0.4 vs. 1.9 ± 0.2 cm, P = 0.04; and 2.6 ± 0.4 vs. 2.0 ± 0.2 cm, P = 0.01, respectively), and lower cardiac output (3.7 ± 1.2 vs. 5.8 ± 0.6 L/min, P = 0.02.). CFD showed significantly lower time-averaged central pulmonary artery WSS in PAH patients compared to controls (4.3 ± 2.8 vs. 20.5 ± 4.0 dynes/cm2, P = 0.0004). Distal WSS was not significantly different. A novel method of measuring WSS was utilized to demonstrate for the first time that WSS is altered in some patients with PAH. Using computational modeling in patient-specific models, WSS was found to be significantly lower in the proximal pulmonary arteries of PAH patients compared to controls. Reduced WSS in proximal pulmonary arteries may play a role in the pathogenesis and progression of PAH. This data may serve as a basis for future in vitro studies of, for example, effects of WSS on gene expression.

[1]  M. Humbert,et al.  Review: Therapeutic advances in pulmonary arterial hypertension , 2008, Therapeutic advances in respiratory disease.

[2]  Jeffrey A. Feinstein,et al.  Three-Dimensional Hemodynamics in the Human Pulmonary Arteries Under Resting and Exercise Conditions , 2010, Annals of Biomedical Engineering.

[3]  L. Ignarro,et al.  Endothelium‐Derived Relaxing Factor From Pulmonary Artery and Vein Possesses Pharmacologic and Chemical Properties Identical to Those of Nitric Oxide Radical , 1987, Circulation research.

[4]  B. Chen,et al.  DNA microarray analysis of gene expression in endothelial cells in response to 24-h shear stress. , 2001, Physiological genomics.

[5]  A Giaid,et al.  Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. , 1995, The New England journal of medicine.

[6]  S. Dudek,et al.  Cytoskeletal regulation of pulmonary vascular permeability. , 2001, Journal of applied physiology.

[7]  P R Hoskins,et al.  Three-dimensional imaging and computational modelling for estimation of wall stresses in arteries. , 2009, The British journal of radiology.

[8]  D. Stewart,et al.  Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. , 1993, The New England journal of medicine.

[9]  D. Chemla,et al.  Haemodynamic evaluation of pulmonary hypertension , 2002, European Respiratory Journal.

[10]  W. Hop,et al.  Pulmonary arterial wall distensibility assessed by intravascular ultrasound in children with congenital heart disease: an indicator for pulmonary vascular disease? , 2002, Chest.

[11]  R. D. Latham,et al.  Pulmonary arterial compliance at rest and exercise in normal humans. , 1990, The American journal of physiology.

[12]  S. Rich,et al.  Primary pulmonary hypertension: a vascular biology and translational research "Work in progress". , 2000, Circulation.

[13]  E H Bergofsky,et al.  Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry , 1991 .

[14]  David A. Schultz,et al.  A mechanosensory complex that mediates the endothelial cell response to fluid shear stress , 2005, Nature.

[15]  Vivek Muthurangu,et al.  Measurement of total pulmonary arterial compliance using invasive pressure monitoring and MR flow quantification during MR-guided cardiac catheterization. , 2005, American journal of physiology. Heart and circulatory physiology.

[16]  Roger Fan,et al.  Dynamic activation of endothelial nitric oxide synthase by Hsp90 , 1998, Nature.

[17]  J. Tardif,et al.  Intravascular ultrasound of the elastic pulmonary arteries: a new approach for the evaluation of primary pulmonary hypertension , 2003, Heart.

[18]  Robert W. Dutton,et al.  A Software Framework for Creating Patient Specific Geometric Models from Medical Imaging Data for Simulation Based Medical Planning of Vascular Surgery , 2001, MICCAI.

[19]  Thomas J. R. Hughes,et al.  Finite element modeling of blood flow in arteries , 1998 .

[20]  S. Alper,et al.  Modulation by pathophysiological stimuli of the shear stress-induced up-regulation of endothelial nitric oxide synthase expression in endothelial cells. , 1999, Neurosurgery.

[21]  M. Humbert,et al.  Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension. , 2004, American journal of respiratory and critical care medicine.

[22]  F. Hosoda,et al.  A BAC-based STS-content map spanning a 35-Mb region of human chromosome 1p35-p36. , 2001, Genomics.

[23]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[24]  S. Nakatani,et al.  Noninvasive estimation of pulmonary vascular resistance by Doppler echocardiography in patients with pulmonary arterial hypertension. , 2009, The American journal of cardiology.

[25]  F. Murad.  The 1996 Albert Lasker Medical Research Awards. Signal transduction using nitric oxide and cyclic guanosine monophosphate. , 1996, JAMA.

[26]  M. Botney,et al.  Role of hemodynamics in pulmonary vascular remodeling: implications for primary pulmonary hypertension. , 1999, American journal of respiratory and critical care medicine.

[27]  A. Al-Mehdi,et al.  Shear stress and endothelial cell activation , 2002, Critical care medicine.

[28]  H. Piene,et al.  Does normal pulmonary impedance constitute the optimum load for the right ventricle? , 1982, American Journal of Physiology.

[29]  S. Rich,et al.  Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. , 1998, The New England journal of medicine.

[30]  K. Pritchard,et al.  Suppression of angiotensin-converting enzyme expression and activity by shear stress. , 1997, Circulation research.

[31]  G. Remuzzi,et al.  Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. , 1995, Circulation research.

[32]  F. Murad.  Signal Transduction Using Nitric Oxide and Cyclic Guanosine Monophosphate , 1996 .

[33]  P. Batchelor,et al.  International Society for Magnetic Resonance in Medicine , 1997 .

[34]  M. Pillinger,et al.  Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension , 2006 .

[35]  M. Reale,et al.  Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. , 1997, Journal of vascular research.

[36]  Pascal Verdonck,et al.  Pulmonary arterial compliance in dogs and pigs: the three-element windkessel model revisited. , 1999, American journal of physiology. Heart and circulatory physiology.

[37]  P. Fourie,et al.  Pulmonary artery compliance: its role in right ventricular-arterial coupling. , 1992, Cardiovascular research.

[38]  G. M. Solov'ev,et al.  [Primary pulmonary hypertension]. , 1961, Terapevticheskii arkhiv.

[39]  R M Nerem,et al.  Endothelial cellular response to altered shear stress. , 2001, American journal of physiology. Lung cellular and molecular physiology.